Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q3 2025 13F
5,222,311
4,185,632
−19.9%
Share count drives classification; reported value also moves with price
0.39%
Within the filing's reported positions, not the manager's total assets
1
For Q4 2025
Insider buying
Traded Mar 18 · filed 1 day later
The CFO of Aldeyra Therapeutics paid $7.1K out of pocket for Aldeyra Therapeutics shares. 1 other person at Aldeyra Therapeutics bought some too, in the same month. Shares held went up 200% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
